Stay up-to-date with advances in chronic kidney disease (CKD)! Join our esteemed Chief of Nephrology at Kashlak Memorial Hospital, Dr. Joel Topf, as he leads us through the latest on SGLT2 inhibitors, finerenone, potassium binders, and treatment of CKD-associated metabolic acidosis.
Claim free CME for this episode at curbsiders.vcuhealth.org!
Episodes | Subscribe | Spotify | YouTube | Mailing List |
[email protected] | Swag! | Free CME!
Show Segments
Intro, disclaimer, guest bioCase from KashlakSGLT2i: when to initiateSGLT2i: adverse effectsFinerenonePotassium bindersTreatment of CKD-associated metabolic acidosis Outro
Credits
Writer, Producer, Show Notes, Infographics, and Cover Art: Malini GandhiHosts: Matthew Watto MD, FACP; Paul Williams MD, FACP Reviewer: Leah Witt MDShowrunners: Matthew Watto MD, FACP; Paul Williams MD, FACPTechnical Production: PodPasteGuest: Dr. Joel Topf MD
Sponsor: Better Help
Visit betterhelp.com/curb today to get 10% off your first month.
Sponsor: Birch Living
Birch is giving 20% off all mattresses and 2 free eco-rest pillows at birchliving.com/curb.
Sponsor: PanaceaFinancial
Visit panaceafinancial.com to open a free account.
Full transcript available HERE